Systemic therapy for sarcoidosis is reserved for organ-threatening disease, and laryngeal involvement necessitates treatment ...

The Emirates Drug Establishment (EDE) has recalled the Hong Thai Herbal Inhaler (Yadom) from the UAE market after laboratory tests confirmed microbial contamination in multiple batches. Following a ...

Metered-dose inhaler propellants have contributed a rising amount to greenhouse gases in the U.S. Emissions per inhaler declined slightly over the past decade, but an increase in annual prescription ...

DEAR DR. ROACH: I’m an 83-year-old man in good health who exercises regularly. I came down with a common cold and was prescribed a five-day course of prednisone (50 mg). I’ve taken two so far. I’ve ...

Inhalers are the frontline treatment for asthma and COPD, but they come with a steep environmental cost, according to a new UCLA Health study—the largest to date quantifying inhaler-related emissions ...

The people who are most vulnerable to the hard-to-breathe air that comes with climate change may inadvertently be adding to the problem, new research finds. About 34 million Americans have a chronic ...

Inhalers that combine providing immediate relief with a longer-term preventative effect are already recommended as the standard treatment for mild asthma among people aged 12 and above in the UK, US ...

A groundbreaking international study has shown that a 2-in-1 budesonide-formoterol inhaler is far more effective than the standard salbutamol inhaler in children with mild asthma, cutting attacks by ...

WASHINGTON, June 27 (Reuters) - U.S. Senator Maggie Hassan said on Friday she is launching an investigation into British pharmaceutical giant GlaxoSmithKline's (GSK.L), opens new tab decision to ...

Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research published at the ATS 2025 International ...

Stephen Hughes receives research grant funding from the Australian Government Department of Health and Aged Care Medical Research Future Fund, The Australian Research Council and Asthma Australia. He ...

More children stopped using steroid inhalers to control their asthma after a manufacturer discontinued a popular inhaler, a new study says. In 2024, GlaxoSmithKline withdrew Flovent from the market.